Lucy Feng

4.8k total citations · 1 hit paper
39 papers, 2.3k citations indexed

About

Lucy Feng is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cell Biology. According to data from OpenAlex, Lucy Feng has authored 39 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 10 papers in Cardiology and Cardiovascular Medicine and 7 papers in Cell Biology. Recurrent topics in Lucy Feng's work include Muscle Physiology and Disorders (27 papers), Cardiomyopathy and Myosin Studies (7 papers) and Neurogenetic and Muscular Disorders Research (6 papers). Lucy Feng is often cited by papers focused on Muscle Physiology and Disorders (27 papers), Cardiomyopathy and Myosin Studies (7 papers) and Neurogenetic and Muscular Disorders Research (6 papers). Lucy Feng collaborates with scholars based in United Kingdom, United States and Italy. Lucy Feng's co-authors include Caroline A. Sewry, Silvia Torelli, Francesco Muntoni, Jennifer E. Morgan, Volker Straub, Stephen Abbs, Sebahattin Çirak, Virginia Arechavala‐Gomeza, Michela Guglieri and Karen Anthony and has published in prestigious journals such as The Lancet, PLoS ONE and Brain.

In The Last Decade

Lucy Feng

37 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

2011 656 citations Sebahattin Çirak, Virginia Arechavala‐Gomeza et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lucy Feng United Kingdom	22	2.0k	456	426	325	297	39	2.3k
Sebahattin Çirak United Kingdom	22	2.1k 1.0×	405 0.9×	392 0.9×	333 1.0×	254 0.9×	41	2.3k
K. Bushby United Kingdom	20	1.4k 0.7×	371 0.8×	265 0.6×	170 0.5×	303 1.0×	49	1.6k
Federica Montanaro United States	22	1.9k 0.9×	258 0.6×	198 0.5×	181 0.6×	399 1.3×	37	2.3k
Ieke B. Ginjaar Netherlands	21	2.2k 1.1×	593 1.3×	477 1.1×	446 1.4×	364 1.2×	37	2.6k
Haiyan Zhou United Kingdom	32	1.8k 0.9×	435 1.0×	764 1.8×	250 0.8×	230 0.8×	74	2.3k
Rita Barresi United Kingdom	19	1.8k 0.9×	542 1.2×	239 0.6×	211 0.6×	451 1.5×	36	2.1k
Anna Sárközy United Kingdom	30	2.4k 1.2×	503 1.1×	192 0.5×	449 1.4×	165 0.6×	91	2.9k
Jane C. Lee United States	14	1.6k 0.8×	352 0.8×	110 0.3×	151 0.5×	489 1.6×	19	1.9k
Stephen Abbs United Kingdom	37	3.0k 1.5×	805 1.8×	853 2.0×	1.0k 3.1×	442 1.5×	83	4.0k
Sara T. Winokur United States	19	2.5k 1.2×	449 1.0×	418 1.0×	984 3.0×	285 1.0×	23	3.1k

Countries citing papers authored by Lucy Feng

Since Specialization

Citations

This map shows the geographic impact of Lucy Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy Feng more than expected).

Fields of papers citing papers by Lucy Feng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucy Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy Feng. The network helps show where Lucy Feng may publish in the future.

Co-authorship network of co-authors of Lucy Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Lucy Feng. A scholar is included among the top collaborators of Lucy Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucy Feng. Lucy Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Munot, Pinki, Silvia Torelli, Adnan Manzur, et al.. (2021). TRAPPC11 ‐related muscular dystrophy with hypoglycosylation of alpha‐dystroglycan in skeletal muscle and brain. Neuropathology and Applied Neurobiology. 48(2). e12771–e12771. 17 indexed citations

Malvankar‐Mehta, Monali S., Lucy Feng, & Cindy Hutnik. (2019). <p>North American cost analysis of brand name versus generic drugs for the treatment of glaucoma</p>. ClinicoEconomics and Outcomes Research. Volume 11. 789–798. 8 indexed citations

Bugiardini, Enrico, Rahul Phadke, David S. Lynch, et al.. (2019). Genetic and phenotypic characterisation of inherited myopathies in a tertiary neuromuscular centre. Neuromuscular Disorders. 29(10). 747–757. 10 indexed citations

Ullmann, Urielle, L. D'Argenzio, Shrey Mathur, et al.. (2018). ECEL1 gene related contractural syndrome: Long-term follow-up and update on clinical and pathological aspects. Neuromuscular Disorders. 28(9). 741–749. 10 indexed citations

Sardone, Valentina, Matthew J. Ellis, Silvia Torelli, et al.. (2018). A novel high-throughput immunofluorescence analysis method for quantifying dystrophin intensity in entire transverse sections of Duchenne muscular dystrophy muscle biopsy samples. PLoS ONE. 13(3). e0194540–e0194540. 17 indexed citations

Humphrey, Emma, Lam Le, Lucy Feng, et al.. (2014). A new monoclonal antibody DAG-6F4 against human alpha-dystroglycan reveals reduced core protein in some, but not all, dystroglycanopathy patients. Neuromuscular Disorders. 25(1). 32–42. 5 indexed citations

Paco, Sonia, Susana G. Kalko, Cristina Jou, et al.. (2013). Gene Expression Profiling Identifies Molecular Pathways Associated with Collagen VI Deficiency and Provides Novel Therapeutic Targets. PLoS ONE. 8(10). e77430–e77430. 12 indexed citations

Stevens, Elizabeth, Silvia Torelli, Lucy Feng, et al.. (2013). Flow Cytometry for the Analysis of α-Dystroglycan Glycosylation in Fibroblasts from Patients with Dystroglycanopathies. PLoS ONE. 8(7). e68958–e68958. 13 indexed citations

Çirak, Sebahattin, Virginia Arechavala‐Gomeza, Michela Guglieri, et al.. (2011). Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. The Lancet. 378(9791). 595–605. 656 indexed citations breakdown →

10.

Robb, S., Caroline A. Sewry, James J. Dowling, et al.. (2011). Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies. Neuromuscular Disorders. 21(6). 379–386. 80 indexed citations

11.

Anthony, Karen, Sebahattin Çirak, Silvia Torelli, et al.. (2011). Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials. Brain. 134(12). 3547–3559. 112 indexed citations

12.

Geranmayeh, Fatemeh, Emma Clement, Lucy Feng, et al.. (2010). Genotype–phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations. Neuromuscular Disorders. 20(4). 241–250. 133 indexed citations

13.

Arechavala‐Gomeza, Virginia, Maria Kinali, Lucy Feng, et al.. (2010). Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: Implication for clinical trials. Neuromuscular Disorders. 20(5). 295–301. 63 indexed citations

14.

Zhou, Haiyan, Suzanne Lillis, Ryan E. Loy, et al.. (2010). Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscular Disorders. 20(3). 166–173. 64 indexed citations

15.

Vi, Linda, Lucy Feng, Yan Wu, et al.. (2009). Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells. Experimental Cell Research. 315(20). 3574–3586. 48 indexed citations

16.

Clement, Emma, Caroline Godfrey, Jenny Tan, et al.. (2008). Mild POMGnT1 Mutations Underlie a Novel Limb-Girdle Muscular Dystrophy Variant. Archives of Neurology. 65(1). 137–41. 57 indexed citations

17.

Piercy, Richard J., Haiyan Zhou, Lucy Feng, et al.. (2007). Desmin immunolocalisation in autosomal dominant Emery-Dreifuss muscular dystrophy. Neuromuscular Disorders. 17(4). 297–305. 7 indexed citations

18.

Godfrey, Caroline, Diana M. Escolar, Martin Brockington, et al.. (2006). Fukutin gene mutations in steroid‐responsive limb girdle muscular dystrophy. Annals of Neurology. 60(5). 603–610. 108 indexed citations

19.

Brockington, Martin, S. Brown, Yeliz Yuva, et al.. (2004). Prenatal diagnosis of Ullrich congenital muscular dystrophy using haplotype analysis and collagen VI immunocytochemistry. Prenatal Diagnosis. 24(6). 440–444. 14 indexed citations

20.

Brown, S., Silvia Torelli, Martin Brockington, et al.. (2004). Abnormalities in α-Dystroglycan Expression in MDC1C and LGMD2I Muscular Dystrophies. American Journal Of Pathology. 164(2). 727–737. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact